🇺🇸 Upfront therapy with oral spironolactone in United States

Upfront therapy with oral spironolactone (Upfront therapy with oral spironolactone) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Upfront therapy with oral spironolactone in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Upfront therapy with oral spironolactone approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Upfront therapy with oral spironolactone in United States?

Hasselt University is the originator. The local marketing authorisation holder may differ — check the official source linked above.